Generic Drugmaker Lannett Hits Ch. 11 With $700M In Debt
Generic drugmaker Lannett filed for Chapter 11 protection in Delaware after striking an agreement with the bulk of its secured creditors and with a plan in hand for an equity swap...To view the full article, register now.
Already a subscriber? Click here to view full article